HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fred Ledon Selected Research

Quinidine (Chinidin)

10/2018Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM-II Open Label Study.
6/2018Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial.
12/2016An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
9/2016Erratum to: PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
6/2016PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fred Ledon Research Topics

Disease

4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2018 - 06/2016
4Multiple Sclerosis
10/2018 - 06/2016
3Traumatic Brain Injuries (Traumatic Brain Injury)
10/2018 - 06/2016
3Stroke (Strokes)
06/2018 - 06/2016
3Dementia (Dementias)
12/2016 - 06/2016
1Hyperemia
05/2012

Drug/Important Bio-Agent (IBA)

5Dextromethorphan (Racemethorphan)FDA LinkGeneric
10/2018 - 06/2016
5Quinidine (Chinidin)FDA LinkGeneric
10/2018 - 06/2016
1Bimatoprost (Lumigan)FDA Link
05/2012